advertisement
advertisement

Nestle partners with Aimmune on food allergy research 

Nestle Health Sciences, part of Nestle’s R&D arm, is investing $145 million into food allergy research through a partnership with Aimmune, a therapeutics company that is working on a treatment candidate for peanut allergies.  It has been estimated that more than 30 million people in the United States and Europe have a food allergy. 

advertisement
advertisement

Nestle Health Sciences, part of Nestle’s R&D arm, is investing $145 million into food allergy research through a partnership with Aimmune, a therapeutics company that is working on a treatment candidate for peanut allergies. 

advertisement

It has been estimated that more than 30 million people in the United States and Europe have a food allergy. 

About the author

Christina Farr is a San Francisco-based journalist specializing in health and technology. Before joining Fast Company, Christina worked as a reporter for VentureBeat, Reuters and KQED

More